Delivery Order SPE2DB22D1017-SPE2DB25FG8YT
Award Date 8/5/25
Potential Completion Date 8/6/25
Potential Value $26K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $29,737.84 and an ultimate completion date of September 10, 2025. The contract was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30-count tablets of DESCOVY 200-25 mg, an antiretroviral medication used in HIV treatment and prevention. This non-set-aside, competitively awarded contract carries a ceiling value of $6,981.93 under a firm fixed-price arrangement, with performance to be completed by September 18, 2025. The delivery order was issued on September 17, 2025, and will be fulfilled from AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $5,208.36 to AmerisourceBergen Drug Corp for 30 tablets of DESCOVY 200-25 mg, an antiretroviral medication used in HIV treatment and prevention. The contract, executed on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, served as the prime...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,002.20 to AmerisourceBergen Drug Corp for 30-unit bottles of DESCOVY 200-25 mg tablets on August 6, 2025, with completion targeted for August 7, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $15,784.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-unit supplies of DESCOVY 200-25 mg tablets, an antiretroviral medication used in HIV treatment and prevention. This non-set-aside competitive award was issued on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on September 18, 2025, for DESCOVY 200-25 mg tablets (30-count units) valued at $23,617.07. This firm fixed-price delivery order, which has a completion deadline of September 19, 2025, was awarded without a set-aside designation through competitive procurement. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral...
- The Defense Logistics Agency awarded a delivery order valued at $30,140.34 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV prevention and treatment,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $47,776.79 on September 17, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30s under a firm fixed-price contract type. This is a non-set-aside award supporting the Department of Defense Medical Supply Chain, with performance at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is expected to be completed by September 18, 2025. DESCOVY is an antiretroviral medication used...
- The Defense Logistics Agency awarded a delivery order valued at $5,842.52 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets in quantities of 30 units. The contract is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for $8,526.60 to supply DESCOVY 200-25 mg tablets in quantities of 30 units. The contract, awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, utilizes firm fixed pricing and is not designated as a set-aside contract. This delivery order is issued under AmerisourceBergen's larger Indefinite...